Álvaro Padrón

1.3k total citations
26 papers, 994 citations indexed

About

Álvaro Padrón is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Álvaro Padrón has authored 26 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Álvaro Padrón's work include Cancer Immunotherapy and Biomarkers (17 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (12 papers). Álvaro Padrón is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Immune Cell Function and Interaction (14 papers) and Immunotherapy and Immune Responses (12 papers). Álvaro Padrón collaborates with scholars based in United States, Brazil and China. Álvaro Padrón's co-authors include Tyler J. Curiel, Vincent Hurez, Justin Drerup, Harshita B. Gupta, Srilakshmi Pandeswara, José R. Conejo-García, Curtis A. Clark, Ratna K. Vadlamudi, Robert S. Svatek and Bin Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Álvaro Padrón

25 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Álvaro Padrón United States 15 516 448 290 107 98 26 994
Shuhong Han United States 20 253 0.5× 549 1.2× 297 1.0× 56 0.5× 39 0.4× 41 1.1k
Steven Messina‐Graham United States 8 201 0.4× 177 0.4× 351 1.2× 156 1.5× 67 0.7× 10 937
Roberto Arriga Italy 15 318 0.6× 257 0.6× 217 0.7× 47 0.4× 26 0.3× 24 656
Lei Gong China 16 159 0.3× 165 0.4× 259 0.9× 79 0.7× 118 1.2× 38 679
Guojin Wu United States 14 184 0.4× 260 0.6× 369 1.3× 37 0.3× 32 0.3× 33 798
Yifang Hu China 15 118 0.2× 333 0.7× 207 0.7× 73 0.7× 99 1.0× 44 757
Miaoqing Zhao China 16 171 0.3× 168 0.4× 425 1.5× 67 0.6× 44 0.4× 75 792
Vincenzo Gigantino Italy 17 165 0.3× 217 0.5× 403 1.4× 45 0.4× 54 0.6× 30 922
Cecilia Evangelisti Italy 18 139 0.3× 212 0.5× 466 1.6× 108 1.0× 50 0.5× 28 928

Countries citing papers authored by Álvaro Padrón

Since Specialization
Citations

This map shows the geographic impact of Álvaro Padrón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Álvaro Padrón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Álvaro Padrón more than expected).

Fields of papers citing papers by Álvaro Padrón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Álvaro Padrón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Álvaro Padrón. The network helps show where Álvaro Padrón may publish in the future.

Co-authorship network of co-authors of Álvaro Padrón

This figure shows the co-authorship network connecting the top 25 collaborators of Álvaro Padrón. A scholar is included among the top collaborators of Álvaro Padrón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Álvaro Padrón. Álvaro Padrón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Padrón, Álvaro, Yilun Deng, Yiji Liao, et al.. (2023). Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects. Journal for ImmunoTherapy of Cancer. 11(2). e004871–e004871. 8 indexed citations
2.
Kornepati, Anand, Clare Murray, Cody M. Rogers, et al.. (2022). Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor–Induced Synthetic Lethality. Cancer Research. 82(11). 2156–2170. 39 indexed citations
3.
Murray, Clare, Yilun Deng, Álvaro Padrón, et al.. (2022). Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents. International Journal of Molecular Sciences. 23(9). 5129–5129. 8 indexed citations
4.
Deng, Yilun, Clare Murray, Álvaro Padrón, et al.. (2022). Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. SHILAP Revista de lepidopterología. 3(1). 68–83. 16 indexed citations
5.
Thibodeaux, Suzanne R., Srilakshmi Pandeswara, Vincent Hurez, et al.. (2021). IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer. Clinical Cancer Research. 27(13). 3661–3673. 12 indexed citations
6.
Zhang, Deyi, Harshita B. Gupta, Álvaro Padrón, et al.. (2021). Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy. Cancer Medicine. 10(6). 2137–2152. 34 indexed citations
7.
Deng, Yilun, Deyi Zhang, Niannian Ji, et al.. (2021). CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation. Journal for ImmunoTherapy of Cancer. 9(4). e002051–e002051. 14 indexed citations
8.
Kornepati, Anand, Clare Murray, Cody M. Rogers, et al.. (2021). 900 Depleting non-canonical, cell-intrinsic PD-L1 signals induces synthetic lethality to small molecule DNA damage response inhibitors in an immune independent and dependent manner. SHILAP Revista de lepidopterología. A944–A944. 2 indexed citations
9.
Drerup, Justin, Yilun Deng, Álvaro Padrón, et al.. (2020). CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade. Cancer Research. 80(22). 5063–5075. 27 indexed citations
10.
Deng, Yilun, Justin Drerup, Xinyue Zhang, et al.. (2020). 690 CD122-selective IL-2 complexes treat ovarian carcinomas, induce Treg fragility and promote T cell stem cells. SHILAP Revista de lepidopterología. A414–A415. 2 indexed citations
11.
Padrón, Álvaro, Vincent Hurez, Harshita B. Gupta, et al.. (2018). Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model. Experimental Gerontology. 105. 146–154. 33 indexed citations
12.
Hurez, Vincent, Álvaro Padrón, Robert S. Svatek, & Tyler J. Curiel. (2017). Considerations for successful cancer immunotherapy in aged hosts. Experimental Gerontology. 107. 27–36. 40 indexed citations
13.
Clark, Curtis A., Harshita B. Gupta, Gangadhara R. Sareddy, et al.. (2016). Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma. Cancer Research. 76(23). 6964–6974. 309 indexed citations
14.
Liu, Yang, Srilakshmi Pandeswara, Vinh Dao, et al.. (2016). Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment. Cancer Research. 77(2). 520–531. 12 indexed citations
15.
Gupta, Harshita B., Curtis A. Clark, Bin Yuan, et al.. (2016). Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer. Signal Transduction and Targeted Therapy. 1(1). 94 indexed citations
16.
Hurez, Vincent, Vinh Dao, Aijie Liu, et al.. (2015). Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice. Aging Cell. 14(6). 945–956. 98 indexed citations
17.
Drerup, Justin, Álvaro Padrón, Kruthi Murthy, et al.. (2015). Immunotherapy for Ovarian Cancer. Current Treatment Options in Oncology. 16(1). 317–317. 45 indexed citations
18.
Padrón, Álvaro, Ruy A. Louzada, Renata Lopes Araújo, et al.. (2014). Administration of 3,5‐diiodothyronine (3,5‐T2) causes central hypothyroidism and stimulates thyroid‐sensitive tissues. Journal of Endocrinology. 221(3). 415–427. 61 indexed citations
19.
Rosenthal, Doris, et al.. (2010). Effect of serum estradiol and leptin levels on thyroid function, food intake and body weight gain in female Wistar rats. Steroids. 75(10). 638–642. 30 indexed citations
20.
Fortunato, Rodrigo S., Álvaro Padrón, Michelle Porto Marassi, et al.. (2008). The effect of acute exercise session on thyroid hormone economy in rats. Journal of Endocrinology. 198(2). 347–353. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuhong Han Breakdown of academic impact, for papers by Steven Messina‐Graham Breakdown of academic impact, for papers by Roberto Arriga Breakdown of academic impact, for papers by Lei Gong Breakdown of academic impact, for papers by Guojin Wu Breakdown of academic impact, for papers by Yifang Hu Breakdown of academic impact, for papers by Miaoqing Zhao Breakdown of academic impact, for papers by Vincenzo Gigantino Breakdown of academic impact, for papers by Cecilia Evangelisti
Rankless by CCL
2026